⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5432069 | 0.76 | — | — | |
| SCHEMBL23518 | 0.74 | — | — | |
| SCHEMBL7129194 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL1118030 | 0.70 | — | — | |
| SCHEMBL2039664 | 0.70 | — | — | |
| Water SCHEMBL11522203 | 0.70 | — | — | |
| SCHEMBL9184120 | 0.70 | — | — | |
| SCHEMBL22557595 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL17395694 | 0.69 | — | — | |
| SCHEMBL21526283 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121952-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | Novo Nordisk Health Care AG (CH) | 2009-11-25 | — | — | EP | claimed |
| WO-2008101957-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | NOVO NORDISK HEALTH CARE AG (DK) | 2008-08-28 | — | — | WO | claimed |
| JP-2007518747-A | — | — | 2007-07-12 | — | — | JP | claimed |
| EP-1708755-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2006-10-11 | — | — | EP | claimed |
| WO-2005070468-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2005-08-04 | — | — | WO | claimed |
| EP-0516074-B1 | Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents | WACKER CHEMIE GMBH (DE) | 1995-09-27 | — | — | EP | claimed |
| US-5278225-A | Comprising (meth)acrylates of alcohol monomer | WACKER-CHEMIE GMBH (DE) | 1994-01-11 | — | — | US | claimed |
| EP-0516074-A1 | Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents | WACKER-CHEMIE GMBH (DE) | 1992-12-02 | — | — | EP | claimed |
| US-20180221438-A1 | MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2018-08-09 | — | — | US | disclosed |
| WO-2016172795-A1 | MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF | Adaerata Limited Partnership (CA) | 2016-11-03 | — | — | WO | disclosed |
| EP-2324056-A1 | GROWTH HORMONE CONJUGATE WITH INCREASED STABILITY | Novo Nordisk Health Care AG (CH) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010029107-A1 | GROWTH HORMONE CONJUGATE WITH INCREASED STABILITY | NOVO NORDISK HEALTH CARE AG (CH) | 2010-03-18 | — | — | WO | disclosed |
| EP-2121952-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | Novo Nordisk Health Care AG (CH) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008101957-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | NOVO NORDISK HEALTH CARE AG (DK) | 2008-08-28 | — | — | WO | disclosed |
| EP-1708755-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2006-10-11 | — | — | EP | disclosed |
| WO-2005070468-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2005-08-04 | — | — | WO | disclosed |
| EP-0516074-B1 | Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents | WACKER CHEMIE GMBH (DE) | 1995-09-27 | — | — | EP | disclosed |
| US-5278225-A | Comprising (meth)acrylates of alcohol monomer | WACKER-CHEMIE GMBH (DE) | 1994-01-11 | — | — | US | disclosed |
| EP-0516074-A1 | Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents | WACKER-CHEMIE GMBH (DE) | 1992-12-02 | — | — | EP | disclosed |